Trial Profile
A Phase 1, Double-blind, Placebo-controlled, Dose Escalation Study of the Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 May 2014
Price :
$35
*
At a glance
- Drugs Peginesatide (Primary)
- Indications Anaemia; Aplastic anaemia
- Focus Adverse reactions
- Sponsors Affymax
- 26 May 2014 New trial record